Resources

Riverlabs is a 440,000 sq ft life science campus in Ware - the intelligent upgrade of existing, purpose-built laboratory spaces will be available for occupation from Q3, 2025.

Intelligent upgrade of existing, purpose-built laboratory spaces will be available for occupation from Q3, 2025.

New St John’s innovation centre strengthens support for technology and life sciences sectors.

In this blog, John Stewart, Vice President of KojoX Strategy and Rasmus Pedersen, Associate Director of Process Technology for FUJIFILM Diosynth Biotechnologies, talk about FUJIFILM's flagship single-use cell culture facility in Billingham, UK.

The North West of England is recognised as one of the cornerstones of the UK’s life sciences  sector. This enduring strength positions the North West as a hub of national significance for life sciences manufacturing.

Imperial, the leading global science university, is achieving a major step up in its life sciences capacity at its White City Deep Tech Campus through a major new joint venture with Bruntwood SciTech.

Cushman & Wakefield's Locating Science life sciences report wins top award from the Society of Property Researchers

Aravax, a clinical-stage biotechnology company developing next-generation immunotherapies designed to be safe, convenient, and precisely targeted, today announces it has established a UK subsidiary, based on the Oxford Science Park, as the company continues its development into an international leader in food allergies.

Facility dedicated to cryopreservation of leukapheresis starting materials to support clinical and commercial cell-based therapy programs

Logical Biological, a leading provider of biological critical materials for diagnostics, therapeutic research, and IVD reagent manufacture, has settled into larger, upgraded laboratory space at Discovery Park, marking its third move within the science and innovation campus.

Symbiosis Pharmaceutical Services Ltd announces the purchase of new premises in Stirling, Scotland, UK. The additional space will double the total footprint of the company across the four facilities that it will operate from, increasing manufacturing capacity by 50% in the short-term.

Ingenza, a world-leading contract research, development and manufacturing organisation (CRDMO) and technology accelerator, has signed a 10-year lease at the Moubray Building at Edinburgh Technopole, part of Pioneer Group.

The UK’s first network of cystic fibrosis innovation hubs is being launched to accelerate the development of new diagnostic tools and therapeutic approaches to detect, treat and manage lung infections.

This development will improve clinical trial infrastructure.

Myricx Bio joins Kadans’ pioneering innovation centre in Canary Wharf, providing the facilities for its future expansion and pipeline progression.

The convergence of science and tech is reshaping key UK markets, with Cambridge and Oxford leading the charge. Download the Bidwells' databooks for detailed insights.

London BioScience Innovation Centre (LBIC) is delighted to announce that it has entered into an Agreement for Lease with Baseimmune Ltd.

The life sciences sector in the UK has been the subject of significant attention over recent years. Activity in the sector has been spurred on by a multitude of drivers and its potential has also been frequently highlighted by the UK government.